BIOTECH
Biogen’s $5.6B Acquisition, AI-Powered Drug Discovery, and the Deals Reshaping the Pharmaceutical Industry
Biopharma Is on the Most Aggressive Buying Spree in Years The first quarter of 2026 has produced nearly $47 billion in biopharma mergers and acquisitions, with deal-hungry pharmaceutical giants paying premium prices for companies that […]